MoneyWorks4Me

The Total revenue for the quarter ended March 2025 of  Rs. 1484.63 millions grew by 102.64% from Rs. 732.66 millions.Net Profit witnessed a 159.40% growth almost the double from Rs. 67.47 millions to Rs. 175.02  millions  of same quarter last year.Operating Profit saw a handsome growth to 243.75 millions from 116.75 millions in the quarter ended March 2025.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 1484.63 732.66 102.64 4628.49 2583.60 79.15 4628.49 2583.60 79.15
Other Income 69.03 28.71 140.44 171.91 131.01 31.22 171.91 131.01 31.22
PBIDT 243.75 116.75 108.78 706.97 409.55 72.62 706.97 409.55 72.62
Interest 0.89 11.70 -92.39 8.50 44.49 -80.89 8.50 44.49 -80.89
PBDT 242.94 105.05 131.26 698.53 364.82 91.47 698.53 364.82 91.47
Depreciation 12.86 12.98 -0.92 51.94 47.22 10.00 51.94 47.22 10.00
PBT 230.08 92.07 149.90 646.59 317.60 103.59 646.59 317.60 103.59
TAX 55.06 24.60 123.82 157.87 81.36 94.04 157.87 81.36 94.04
Deferred Tax 10.05 0.43 2237.21 13.34 5.54 140.79 13.34 5.54 140.79
PAT 175.02 67.47 159.40 488.72 236.24 106.87 488.72 236.24 106.87
Equity 940.00 940.00 0.00 940.00 940.00 0.00 940.00 940.00 0.00
PBIDTM(%) 16.42 15.94 3.03 15.27 15.85 -3.64 15.27 15.85 -3.64
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..